Loading clinical trials...
Loading clinical trials...
To determine the effects of 12 weeks administration of different dose levels of ALV003 on the mucosal lining of the small intestine and symptoms in celiac disease patients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alvine Pharmaceuticals Inc.
NCT07362654 · Celiac Disease, Gluten Sensitivity, and more
NCT07239336 · Celiac Disease
NCT07039773 · Celiac Disease
NCT06356220 · Celiac Disease in Children, Nutrition Disorder, Child
NCT07069127 · Celiac Disease, Dentin Hypersensitivity, and more
Decatur, Alabama
Huntsville, Alabama
Huntsville, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions